# Therapy Management With Nab-Paclitaxel in Daily Routine

> **NCT02642406** · — · UNKNOWN · sponsor: **University Hospital Tuebingen** · enrollment: 1200 (estimated)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02642406
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2021-09
- **Final completion:** 2021-12
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02642406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02642406, "Therapy Management With Nab-Paclitaxel in Daily Routine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02642406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*